Ph Health Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MIDODRINE HYDROCHLORIDE USP, with a corresponding US DMF Number 28211.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 01, 2014, and payment made on April 29, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II